Perceptive Advisors LLC — 13F Holdings

2026 Q3  ·  135 Positions

2026 Q3 Portfolio Activity

In 2026 Q3, PERCEPTIVE ADVISORS LLC maintained a portfolio of 135 distinct positions. The most significant new addition was FREENOME INC, now representing 3.46% of the total fund value. They heavily accumulated shares in MODERNA INC, increasing the position by 40.0%. Conversely, PERCEPTIVE ADVISORS LLC completely exited their position in NUVALENT INC.
Position History hover any row below to update
Loading…
PERCEPTIVE ADVISORS LLC New York, NY Hedge Fund AUM $5,329M
PCA Score Concentration Risk
Risk ENB
Total Positions
135
Quarter
2026 Q3
Top Holding
PRAX (10.3%)
Top 10 Concentration
49.7%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 135

PERCEPTIVE ADVISORS LLC Full Holdings List — 2026 Q3

Stock History Sector / Type Port % Prev % Rank / Prev Conviction
Freshness
Change % Change Influence Shares Mkt Value Avg Cost Price Held 1st Owned Source Source Date Date Reported
PRAX
PRAXIS PRECISIO...
Healthcare 10.27% 10.23% #1
Prev: #1
6.5
—
-11,205 -0.6%
P
S
2,024,781 $589,676,971 2024 Q1 13F Filing 2026-09-30 2026-11-16
AMLX
AMYLYX PHARMACE...
Healthcare 5.36% 2.25% #2 11
Prev: #13
6.1
—
2,238,853 26.9%
P
S
10,573,735 $307,695,689 2022 Q1 13F Filing 2026-09-30 2026-11-16
SYRE
SPYRE THERAPEUT...
Healthcare 5.09% 5.76% #3 1
Prev: #2
3.0
—
-1,038,553 -24.0%
P
S
3,280,943 $292,102,355 2023 Q3 13F Filing 2026-09-30 2026-11-16
MRNA
MODERNA INC
PUT
PUT Option 4.70% 1.05% #4 22
Prev: #26
4.9
—
400,000 40.0%
P
S
1,400,000 $269,598,000 2020 Q2 13F Filing 2026-09-30 2026-11-16
CELC
CELCUITY INC
Healthcare 4.40% 5.02% #5 2
Prev: #3
2.8
—
-17,406 -0.5%
P
S
3,179,794 $252,857,219 2023 Q4 13F Filing 2026-09-30 2026-11-16
RYTM
RHYTHM PHARMACE...
Healthcare 4.20% 4.31% #6 1
Prev: #5
2.2
—
-53,739 -2.1%
P
S
2,532,556 $241,137,320 2017 Q4 13F Filing 2026-09-30 2026-11-16
ROIV
ROIVANT SCIENCE...
Healthcare 4.15% 4.30% #7 1
Prev: #6
2.2
—
-1,574,500 -19.5%
P
S
6,510,961 $238,105,844 2022 Q4 13F Filing 2026-09-30 2026-11-16
RLAY
RELAY THERAPEUT...
Healthcare 4.00% 3.96% #8 1
Prev: #7
2.1
—
-1,375,851 -9.8%
P
S
12,730,336 $229,782,565 2020 Q3 13F Filing 2026-09-30 2026-11-16
ASND
ASCENDIS PHARMA...
Healthcare 3.86% 4.66% #9 5
Prev: #4
2.0
—
-192,200 -16.5%
P
S
971,521 $221,341,629 2015 Q1 13F Filing 2026-09-30 2026-11-16
TVTX
TRAVERE THERAPE...
Healthcare 3.63% 3.20% #10 2
Prev: #8
2.0
—
-209,661 -5.6%
P
S
3,542,913 $208,606,717 2020 Q4 13F Filing 2026-09-30 2026-11-16
FRNM
FREENOME INC
Healthcare 3.46% — #11
Prev: #—
4.9
—
12,606,053 —
NEW
12,606,053 $198,545,334 2026 Q3 13F Filing 2026-09-30 2026-11-16
EWTX
EDGEWISE THERAP...
Healthcare 2.93% 2.67% #12 1
Prev: #11
1.7
—
-235,692 -5.4%
P
S
4,138,282 $168,014,249 2023 Q4 13F Filing 2026-09-30 2026-11-16
INBX
INHIBRX BIOSCIE...
Healthcare 2.25% 1.85% #13 3
Prev: #16
1.4
—
-5,300 -0.4%
P
S
1,292,463 $129,349,697 2021 Q2 13F Filing 2026-09-30 2026-11-16
NRIX
NURIX THERAPEUT...
Healthcare 2.22% 1.57% #14 8
Prev: #22
3.4
—
1,051,207 24.3%
P
S
5,371,629 $127,361,324 2024 Q4 13F Filing 2026-09-30 2026-11-16
KARD
KARDIGAN INC
Healthcare 2.11% 2.94% #15 6
Prev: #9
1.8
—
no change no change
P
S
8,200,662 $120,959,764 2026 Q2 13F Filing 2026-09-30 2026-11-16
MGTX
MEIRAGTX HLDGS ...
Healthcare 2.07% 2.19% #16 2
Prev: #14
1.8
—
no change no change
P
S
10,786,658 $118,653,238 2018 Q2 13F Filing 2026-09-30 2026-11-16
PTGX
PROTAGONIST THE...
Healthcare 2.05% 1.81% #17
Prev: #17
1.3
—
-145,300 -14.8%
P
S
836,579 $117,865,615 2020 Q4 13F Filing 2026-09-30 2026-11-16
IMTX
IMMATICS N.V
Healthcare 1.72% 1.58% #18 3
Prev: #21
2.7
—
863,060 8.3%
P
S
11,246,516 $98,744,410 2020 Q3 13F Filing 2026-09-30 2026-11-16
ZYME
ZYMEWORKS INC
Healthcare 1.64% 1.64% #19
Prev: #19
1.2
—
-637,452 -15.2%
P
S
3,545,501 $93,920,321 2022 Q4 13F Filing 2026-09-30 2026-11-16
ORKA
ORUKA THERAPEUT...
Healthcare 1.56% 1.92% #20 5
Prev: #15
0.6
—
-272,700 -20.3%
P
S
1,072,363 $89,317,114 2024 Q3 13F Filing 2026-09-30 2026-11-16
RVMD
REVOLUTION MEDI...
Healthcare 1.55% 1.48% #21 3
Prev: #24
1.1
—
-94,500 -17.9%
P
S
433,100 $88,898,106 2020 Q1 13F Filing 2026-09-30 2026-11-16
SLDB
SOLID BIOSCIENC...
Healthcare 1.50% 1.79% #22 4
Prev: #18
1.6
—
no change no change
P
S
11,906,646 $86,085,050 2022 Q4 13F Filing 2026-09-30 2026-11-16
BCRX
BIOCRYST PHARMA...
Healthcare 1.49% 1.55% #23
Prev: #23
1.1
—
-7,000 -0.1%
P
S
10,301,888 $85,814,727 2002 Q4 13F Filing 2026-09-30 2026-11-16
AVLN
AVALYN PHARMACE...
Healthcare 1.33% 1.32% #24 1
Prev: #25
1.5
—
no change no change
P
S
2,675,296 $76,219,183 2026 Q2 13F Filing 2026-09-30 2026-11-16
TNGX
TANGO THERAPEUT...
Healthcare 1.17% 1.58% #25 5
Prev: #20
0.5
—
-684,000 -20.3%
P
S
2,693,000 $67,190,350 2023 Q3 13F Filing 2026-09-30 2026-11-16
WAT
WATERS CORP
Healthcare 1.03% — #26
Prev: #—
3.9
—
135,000 —
NEW
135,000 $59,317,650 2026 Q3 13F Filing 2026-09-30 2026-11-16
RGEN
REPLIGEN CORP
Healthcare 0.91% 0.51% #27 15
Prev: #42
2.4
—
24,244 9.8%
P
S
272,456 $52,374,217 2002 Q4 13F Filing 2026-09-30 2026-11-16
AORT
ARTIVION INC
Healthcare 0.84% 0.59% #28 11
Prev: #39
2.8
—
375,000 21.6%
P
S
2,112,290 $48,202,458 2016 Q3 13F Filing 2026-09-30 2026-11-16
ANRO
ALTO NEUROSCIEN...
Healthcare 0.78% 0.64% #29 5
Prev: #34
2.3
—
151,057 9.4%
P
S
1,760,950 $44,957,054 2025 Q3 13F Filing 2026-09-30 2026-11-16
IRD
OPUS GENETICS I...
Healthcare 0.76% — #30
Prev: #—
3.8
—
9,000,000 —
NEW
9,000,000 $43,560,000 2025 Q1 13F Filing 2026-09-30 2026-11-16
SLS
SELLAS LIFE SCI...
CALL
CALL Option 0.64% — #31
Prev: #—
3.8
—
3,000,000 —
NEW
3,000,000 $36,930,000 2026 Q2 13F Filing 2026-09-30 2026-11-16
GLPG
LAKEFRONT BIOTH...
Healthcare 0.64% — #32
Prev: #—
3.8
—
1,242,404 —
NEW
1,242,404 $36,837,278 2015 Q2 13F Filing 2026-09-30 2026-11-16
ABT
ABBOTT LABORATO...
Healthcare 0.59% — #33
Prev: #—
3.7
—
345,225 —
NEW
345,225 $34,118,587 2008 Q2 13F Filing 2026-09-30 2026-11-16
BLSM
BLOSSOMHILL THE...
Healthcare 0.59% — #34
Prev: #—
3.7
—
1,812,193 —
NEW
1,812,193 $33,779,278 2026 Q3 13F Filing 2026-09-30 2026-11-16
XBI
SPDR SERIES TRU...
PUT
PUT Option 0.55% 0.71% #35 4
Prev: #31
0.2
—
-100,000 -33.3%
P
S
200,000 $31,536,000 2015 Q2 13F Filing 2026-09-30 2026-11-16
OBIO
ORCHESTRA BIOME...
Healthcare 0.55% 0.33% #36 22
Prev: #58
0.7
—
-300 -0.0%
P
S
5,037,606 $31,333,909 2023 Q1 13F Filing 2026-09-30 2026-11-16
SLS
SELLAS LIFE SCI...
PUT
PUT Option 0.54% 0.33% #37 19
Prev: #56
3.2
—
1,000,000 66.7%
P
S
2,500,000 $30,775,000 2026 Q2 13F Filing 2026-09-30 2026-11-16
CRVS
CORVUS PHARMACE...
Healthcare 0.50% 0.60% #38 2
Prev: #36
0.7
—
-157,000 -5.9%
P
S
2,510,441 $28,920,280 2025 Q2 13F Filing 2026-09-30 2026-11-16
AVR
ANTERIS TECHNOL...
Healthcare 0.46% 0.51% #39 4
Prev: #43
1.2
—
no change no change
P
S
3,425,476 $26,615,949 2024 Q4 13F Filing 2026-09-30 2026-11-16
ANL
ADLAI NORTYE GR...
Healthcare 0.46% 0.31% #40 20
Prev: #60
0.7
—
-132,688 -7.4%
P
S
1,660,502 $26,568,032 2026 Q2 13F Filing 2026-09-30 2026-11-16
N/A
MINIMED GROUP I...
Unknown 0.45% — #41
Prev: #—
3.7
—
1,320,000 —
NEW
1,320,000 $25,700,400 — 13F Filing 2026-09-30 2026-11-16
CTMX
CYTOMX THERAPEU...
Healthcare 0.44% 0.59% #42 4
Prev: #38
0.7
—
-1,171,124 -11.2%
P
S
9,268,061 $25,209,126 2015 Q4 13F Filing 2026-09-30 2026-11-16
RAPP
RAPPORT THERAPE...
Healthcare 0.42% 0.48% #43 1
Prev: #44
0.7
—
-49,000 -6.3%
P
S
724,342 $24,337,891 2024 Q2 13F Filing 2026-09-30 2026-11-16
SEPN
SEPTERNA INC
Healthcare 0.39% — #44
Prev: #—
3.7
—
567,479 —
NEW
567,479 $22,205,453 2024 Q4 13F Filing 2026-09-30 2026-11-16
XFOR
X4 PHARMACEUTIC...
Healthcare 0.37% 0.56% #45 5
Prev: #40
0.6
—
-583,000 -7.3%
P
S
7,350,491 $21,316,424 2025 Q4 13F Filing 2026-09-30 2026-11-16
ELVN
ENLIVEN THERAPE...
Healthcare 0.37% — #46
Prev: #—
3.6
—
462,506 —
NEW
462,506 $21,201,275 2026 Q3 13F Filing 2026-09-30 2026-11-16
SABS
SAB BIOTHERAPEU...
Healthcare 0.37% 0.39% #47 5
Prev: #52
1.1
—
no change no change
P
S
6,627,501 $21,009,178 2025 Q4 13F Filing 2026-09-30 2026-11-16
DYN
DYNE THERAPEUTI...
Healthcare 0.36% 0.90% #48 21
Prev: #27
0.1
—
-1,423,873 -52.9%
P
S
1,265,362 $20,384,982 2020 Q3 13F Filing 2026-09-30 2026-11-16
EOLS
EVOLUS INC
Healthcare 0.34% 0.26% #49 17
Prev: #66
1.1
—
no change no change
P
S
2,459,285 $19,674,280 2019 Q1 13F Filing 2026-09-30 2026-11-16
YARW
YARROW BIOSCIEN...
Healthcare 0.32% — #50
Prev: #—
3.6
—
813,098 —
NEW
813,098 $18,310,966 2026 Q3 13F Filing 2026-09-30 2026-11-16
Showing 1-50 of 135 holdings

Unlock Full PERCEPTIVE ADVISORS LLC Analysis

PRO subscribers get access to all historical quarters, Excel/CSV exports, Portfolio Concentration Analytics (PCA), and Risk-Based ENB.

Full Historical Quarters
Excel & CSV Export
PCA & Risk-Based ENB
Auto Cost Basis
Position Change Alerts
Price-Held Analytics
Full history →